The Next Drugs:
An Atlantic Policy Update on Biosimilars

June 7, 2017
Washington, DC

Biosimilars – and the policy and regulatory debates surrounding these complex large-molecule drugs – continue to be a hot topic in Washington.  A patent case in front of the Supreme Court and laws making their way through Congress have the potential to change the market and industry.

The Atlantic convened key stakeholders to discuss the state of and future for biosimilars. What impact will ongoing regulatory and policy considerations have? What can stakeholders expect when it comes to patents and exclusivity? And what effect will the priorities of leadership in Congress and the Administration have on the industry across the next few years?

Watch full session videos

Presented by

Atlantic Live



  • Wednesday, June 07
  • 8:20 a.m.WelcomeEmily Akhtarzandi, Managing Director, AtlanticLIVE
    Chester “Chip” Davis, Jr., President and CEO, Association for Accessible Medicines
  • 8:30 a.m.The Role of CongressRepresentative Peter Welch (D-VT)
    With Steve Clemons, Washington Editor at Large, The Atlantic
  • 8:50 a.m.The Patent LandscapeBruce Artim, Senior Director, Federal Government Affairs, Eli Lilly and Company
    Courtenay Brinckerhoff, Partner, Foley & Lardner LLP
    Phil Nickson, Associate General Counsel, Intellectual Property, Momenta Pharmaceuticals
    With Olga Khazan, Staff Writer, The Atlantic
  • 9:20 a.m.Closing ThoughtsEmily Akhtarzandi, AtlanticLIVE


Also in This Series

Upcoming Events

  • Health Care

    The Atlantic + Discovery Present: Invisible Killers

    In partnership with Discovery, The Atlantic will host the world premiere screening of INVISIBLE KILLERS – a three-part series examining the ongoing battle between humans and viruses – followed by a conversation on stage with leading public health experts to explore the state of our preparedness.

  • Economy/Business

    The Renewal Summit

    Join The Atlantic in the Crescent City during its tricentennial for this year’s Renewal Summit, where we will examine the lessons we can learn from New Orleans’ comeback, and meet the winners of the third annual Renewal Awards.

  • Health Care

    Cancer and the Community

    At Cancer and the Community, The Atlantic will explore the intersection of cancer breakthroughs and community care.